Rank | Gene Set | Z-score |
---|---|---|
1 | glycosphingolipid catabolic process (GO:0046479) | 5.43110521 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.28720016 |
3 | synaptic vesicle exocytosis (GO:0016079) | 5.20054406 |
4 | synaptic vesicle maturation (GO:0016188) | 5.19376276 |
5 | glycolipid catabolic process (GO:0019377) | 5.02791778 |
6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.85747085 |
7 | protein localization to endosome (GO:0036010) | 4.75563685 |
8 | oligosaccharide catabolic process (GO:0009313) | 4.74016849 |
9 | vocalization behavior (GO:0071625) | 4.59227577 |
10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.55608565 |
11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.54773863 |
12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.54112538 |
13 | glutamate secretion (GO:0014047) | 4.50034013 |
14 | locomotory exploration behavior (GO:0035641) | 4.49017227 |
15 | cellular potassium ion homeostasis (GO:0030007) | 4.37150898 |
16 | ceramide catabolic process (GO:0046514) | 4.33797248 |
17 | regulation of synaptic vesicle transport (GO:1902803) | 4.31092477 |
18 | Golgi transport vesicle coating (GO:0048200) | 4.22543433 |
19 | COPI coating of Golgi vesicle (GO:0048205) | 4.22543433 |
20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.22402019 |
21 | neurotransmitter secretion (GO:0007269) | 4.17774343 |
22 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.17040773 |
23 | membrane lipid catabolic process (GO:0046466) | 4.15513394 |
24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.13897594 |
25 | regulation of early endosome to late endosome transport (GO:2000641) | 4.10178647 |
26 | phagosome maturation (GO:0090382) | 4.10021078 |
27 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.09762098 |
28 | sphingolipid catabolic process (GO:0030149) | 4.07902542 |
29 | protein localization to synapse (GO:0035418) | 4.01667370 |
30 | sodium ion export (GO:0071436) | 3.98614615 |
31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.90468096 |
32 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86284983 |
33 | amino sugar catabolic process (GO:0046348) | 3.68096291 |
34 | neuronal action potential propagation (GO:0019227) | 3.64481149 |
35 | proline transport (GO:0015824) | 3.62051019 |
36 | regulation of synapse structural plasticity (GO:0051823) | 3.57496021 |
37 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.54868450 |
38 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.53913609 |
39 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.53781906 |
40 | barbed-end actin filament capping (GO:0051016) | 3.52264317 |
41 | neurotransmitter transport (GO:0006836) | 3.49355000 |
42 | eosinophil chemotaxis (GO:0048245) | 3.48337118 |
43 | neuron cell-cell adhesion (GO:0007158) | 3.47963642 |
44 | cellular copper ion homeostasis (GO:0006878) | 3.44383022 |
45 | response to thyroid hormone (GO:0097066) | 3.42555237 |
46 | exploration behavior (GO:0035640) | 3.37422241 |
47 | neuron-neuron synaptic transmission (GO:0007270) | 3.36958991 |
48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.35934316 |
49 | activation of protein kinase A activity (GO:0034199) | 3.35619788 |
50 | gamma-aminobutyric acid transport (GO:0015812) | 3.30885178 |
51 | iron ion transport (GO:0006826) | 3.28493358 |
52 | glutamate receptor signaling pathway (GO:0007215) | 3.28452892 |
53 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.26782105 |
54 | synaptic transmission, glutamatergic (GO:0035249) | 3.26347856 |
55 | positive regulation of leukocyte degranulation (GO:0043302) | 3.25074556 |
56 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.23720903 |
57 | layer formation in cerebral cortex (GO:0021819) | 3.22820749 |
58 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.22699885 |
59 | response to histamine (GO:0034776) | 3.21643268 |
60 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.21583054 |
61 | positive regulation of membrane potential (GO:0045838) | 3.21232094 |
62 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.20111018 |
63 | intracellular pH reduction (GO:0051452) | 3.19327869 |
64 | pH reduction (GO:0045851) | 3.19170677 |
65 | regulation of neurotransmitter secretion (GO:0046928) | 3.16462826 |
66 | positive regulation of receptor recycling (GO:0001921) | 3.16421686 |
67 | long-term synaptic potentiation (GO:0060291) | 3.16325283 |
68 | long-term memory (GO:0007616) | 3.15063154 |
69 | cell communication by electrical coupling (GO:0010644) | 3.14405190 |
70 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.13155995 |
71 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.11666858 |
72 | synaptic vesicle endocytosis (GO:0048488) | 3.10640559 |
73 | ganglioside metabolic process (GO:0001573) | 3.10450316 |
74 | neuromuscular process controlling posture (GO:0050884) | 3.08708619 |
75 | positive regulation of synapse maturation (GO:0090129) | 3.08612556 |
76 | eosinophil migration (GO:0072677) | 3.08248189 |
77 | regulation of neurotransmitter levels (GO:0001505) | 3.07886783 |
78 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.07314247 |
79 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.04586877 |
80 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.03888189 |
81 | potassium ion homeostasis (GO:0055075) | 3.02468454 |
82 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.02184358 |
83 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.01263177 |
84 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.00373674 |
85 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.00373674 |
86 | transferrin transport (GO:0033572) | 2.98019307 |
87 | amino acid import (GO:0043090) | 2.96906243 |
88 | regulation of cellular pH (GO:0030641) | 2.96790331 |
89 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.95580368 |
90 | regulation of vesicle fusion (GO:0031338) | 2.95458648 |
91 | regulation of neurotransmitter transport (GO:0051588) | 2.94870737 |
92 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.94817112 |
93 | membrane depolarization during action potential (GO:0086010) | 2.94807469 |
94 | regulation of intracellular pH (GO:0051453) | 2.94769885 |
95 | regulation of postsynaptic membrane potential (GO:0060078) | 2.93796789 |
96 | positive regulation of neurotransmitter transport (GO:0051590) | 2.93691544 |
97 | response to auditory stimulus (GO:0010996) | 2.93480605 |
98 | positive regulation of regulated secretory pathway (GO:1903307) | 2.90381114 |
99 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.90082228 |
100 | membrane hyperpolarization (GO:0060081) | 2.89502043 |
101 | cellular response to arsenic-containing substance (GO:0071243) | 2.89220232 |
102 | potassium ion import (GO:0010107) | 2.88709426 |
103 | regulation of synaptic plasticity (GO:0048167) | 2.85383927 |
104 | regulation of mononuclear cell migration (GO:0071675) | 2.84274759 |
105 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.83464567 |
106 | striatum development (GO:0021756) | 2.82422300 |
107 | vesicle transport along microtubule (GO:0047496) | 2.82349929 |
108 | N-acetylneuraminate metabolic process (GO:0006054) | 2.81371711 |
109 | regulation of podosome assembly (GO:0071801) | 2.81211499 |
110 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.79711622 |
111 | osteoclast differentiation (GO:0030316) | 2.79548743 |
112 | response to lipoprotein particle (GO:0055094) | 2.79397190 |
113 | ferric iron transport (GO:0015682) | 2.77871614 |
114 | trivalent inorganic cation transport (GO:0072512) | 2.77871614 |
115 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.77556205 |
116 | cellular iron ion homeostasis (GO:0006879) | 2.75974162 |
117 | positive regulation of synaptic transmission (GO:0050806) | 2.75960195 |
118 | mating behavior (GO:0007617) | 2.73851361 |
119 | glycine transport (GO:0015816) | 2.70492533 |
120 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.70052266 |
121 | synaptic transmission (GO:0007268) | 2.69970931 |
122 | glucose 6-phosphate metabolic process (GO:0051156) | 2.69627158 |
123 | membrane depolarization (GO:0051899) | 2.68939258 |
124 | cellular transition metal ion homeostasis (GO:0046916) | 2.68581168 |
125 | membrane repolarization (GO:0086009) | 2.67759061 |
126 | vesicle coating (GO:0006901) | 2.67753699 |
127 | postsynaptic membrane organization (GO:0001941) | 2.66337303 |
128 | regulation of superoxide anion generation (GO:0032928) | 2.66129260 |
129 | serine transport (GO:0032329) | 2.66052915 |
130 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.65559407 |
131 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.65050904 |
132 | neuromuscular process controlling balance (GO:0050885) | 2.64835885 |
133 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.64159194 |
134 | cellular sodium ion homeostasis (GO:0006883) | 2.62828714 |
135 | angiotensin maturation (GO:0002003) | 2.62394084 |
136 | cell adhesion mediated by integrin (GO:0033627) | 2.62124079 |
137 | vitamin D metabolic process (GO:0042359) | 2.60938488 |
138 | apoptotic cell clearance (GO:0043277) | 2.60803484 |
139 | prepulse inhibition (GO:0060134) | 2.60179379 |
140 | stress fiber assembly (GO:0043149) | 2.57287673 |
141 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.56958883 |
142 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.56952687 |
143 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.56176752 |
144 | long term synaptic depression (GO:0060292) | 2.56163067 |
145 | establishment of synaptic vesicle localization (GO:0097480) | 2.56157401 |
146 | synaptic vesicle transport (GO:0048489) | 2.56157401 |
147 | regulation of regulated secretory pathway (GO:1903305) | 2.55802111 |
148 | synapse assembly (GO:0007416) | 2.55623024 |
149 | regulation of synaptic transmission (GO:0050804) | 2.55544886 |
150 | regulation of female receptivity (GO:0045924) | 2.54891502 |
151 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.54854706 |
152 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.54753303 |
153 | regulation of ARF protein signal transduction (GO:0032012) | 2.53985979 |
154 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.53850069 |
155 | sphingosine metabolic process (GO:0006670) | 2.53238960 |
156 | regulation of receptor recycling (GO:0001919) | 2.51337394 |
157 | copper ion homeostasis (GO:0055070) | 2.49751379 |
158 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.47474100 |
159 | neutrophil activation involved in immune response (GO:0002283) | 2.43159868 |
160 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.42977823 |
161 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42387661 |
162 | L-serine transport (GO:0015825) | 2.42374949 |
163 | glycosphingolipid metabolic process (GO:0006687) | 2.42276690 |
164 | glucosamine-containing compound catabolic process (GO:1901072) | 2.40345518 |
165 | decidualization (GO:0046697) | 2.38791454 |
166 | regulation of leukocyte degranulation (GO:0043300) | 2.38726136 |
167 | fructose metabolic process (GO:0006000) | 2.38493772 |
168 | negative regulation of interleukin-17 production (GO:0032700) | 2.38299433 |
169 | response to peptidoglycan (GO:0032494) | 2.37422655 |
170 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.33363740 |
171 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.33000938 |
172 | cellular monovalent inorganic cation homeostasis (GO:0030004) | 2.31825416 |
173 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.30904885 |
174 | COPII vesicle coating (GO:0048208) | 2.30711462 |
175 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.30677439 |
176 | regulation of cholesterol storage (GO:0010885) | 2.28309723 |
177 | response to acidic pH (GO:0010447) | 2.26482884 |
178 | regulation of cellular amide metabolic process (GO:0034248) | 2.25871414 |
179 | transition metal ion transport (GO:0000041) | 2.25829487 |
180 | peptide catabolic process (GO:0043171) | 2.25628305 |
181 | positive regulation of macroautophagy (GO:0016239) | 2.25559268 |
182 | adhesion of symbiont to host cell (GO:0044650) | 2.25348303 |
183 | virion attachment to host cell (GO:0019062) | 2.25348303 |
184 | lysosome organization (GO:0007040) | 2.25306337 |
185 | lytic vacuole organization (GO:0080171) | 2.25306337 |
186 | adenosine receptor signaling pathway (GO:0001973) | 2.24569694 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.10703245 |
2 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.86279817 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.64260867 |
4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.49869483 |
5 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34266549 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.29840632 |
7 | TFEB_21752829_ChIP-Seq_HELA_Human | 3.03822908 |
8 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.97781284 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96785634 |
10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.95025372 |
11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.91294700 |
12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.89653198 |
13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.88789463 |
14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.83885475 |
15 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.76898762 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57486990 |
17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.51277112 |
18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.47579666 |
19 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.44500279 |
20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44434995 |
21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.39948067 |
22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37915194 |
23 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.35521457 |
24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.34571943 |
25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34291491 |
26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34291491 |
27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.32641041 |
28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.31042828 |
29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.27590951 |
30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26658230 |
31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.23017849 |
32 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.14622431 |
33 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08924162 |
34 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.06176525 |
35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.04746286 |
36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99978861 |
37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98733693 |
38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.93016262 |
39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87453694 |
40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.84639303 |
41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.81835127 |
42 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.76319096 |
43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.74952852 |
44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72680488 |
45 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72649853 |
46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72554399 |
47 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.68386668 |
48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67381529 |
49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67287583 |
50 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.63855113 |
51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.63611544 |
52 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.61949069 |
53 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56325535 |
54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55565009 |
55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.55127997 |
56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52599234 |
57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.52421338 |
58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52384813 |
59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.51822671 |
60 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.51712760 |
61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50768350 |
62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.49769681 |
63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.47860146 |
64 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.47618297 |
65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.43665263 |
66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42505223 |
67 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38018775 |
68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37503828 |
69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.37421372 |
70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37072975 |
71 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.36854618 |
72 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.33462434 |
73 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.33239903 |
74 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.33205265 |
75 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.33205265 |
76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31742059 |
77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31714116 |
78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29921347 |
79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.29476390 |
80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29308050 |
81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28335415 |
82 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27448545 |
83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27062921 |
84 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26985624 |
85 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26561932 |
86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26236763 |
87 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24725717 |
88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24624221 |
89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24324337 |
90 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.24049798 |
91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23589434 |
92 | P300_19829295_ChIP-Seq_ESCs_Human | 1.22720175 |
93 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21921804 |
94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16887703 |
95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15867238 |
96 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15277156 |
97 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14931344 |
98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14062094 |
99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13910041 |
100 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13795240 |
101 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13770042 |
102 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13089571 |
103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11797296 |
104 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.11544409 |
105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10945028 |
106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10779195 |
107 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09812288 |
108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09644023 |
109 | AR_19668381_ChIP-Seq_PC3_Human | 1.09619464 |
110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09340127 |
111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08630400 |
112 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07868319 |
113 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.07779386 |
114 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07139438 |
115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06896289 |
116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06737237 |
117 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05953510 |
118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05846097 |
119 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05817053 |
120 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.04709789 |
121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04670736 |
122 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04616700 |
123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04163602 |
124 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03793483 |
125 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01692009 |
126 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00933188 |
127 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00917133 |
128 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00355460 |
129 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00316948 |
130 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99863504 |
131 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99469314 |
132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99438510 |
133 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99389098 |
134 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99148774 |
135 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99142159 |
136 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98644395 |
137 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98146412 |
138 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97565878 |
139 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.97339192 |
140 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97275719 |
141 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96667288 |
142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96459928 |
143 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96390010 |
144 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95226549 |
145 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95191349 |
146 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95095613 |
147 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94440328 |
148 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94348655 |
149 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.94067949 |
150 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92875560 |
151 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.92617349 |
152 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92347791 |
153 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92299497 |
154 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92150785 |
155 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91891829 |
156 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91792854 |
157 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.90630047 |
158 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90556714 |
159 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90473604 |
160 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90281307 |
161 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90209934 |
162 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89838099 |
163 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.89746800 |
164 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89569214 |
165 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89547792 |
166 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89096263 |
167 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88418647 |
168 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.87678498 |
169 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86531069 |
170 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86023323 |
171 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.85670329 |
172 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85243517 |
173 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.84719758 |
174 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84600481 |
175 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84421249 |
176 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84421227 |
177 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84334646 |
178 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83845484 |
179 | VDR_22108803_ChIP-Seq_LS180_Human | 0.83372505 |
180 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.82630553 |
181 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.82363513 |
182 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82029450 |
183 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81908142 |
184 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80787182 |
185 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.80041616 |
186 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78888748 |
187 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78586957 |
188 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78586957 |
189 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.77517908 |
190 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.77291231 |
191 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76898928 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.38108046 |
2 | MP0009840_abnormal_foam_cell | 4.06067438 |
3 | MP0003880_abnormal_central_pattern | 4.01108822 |
4 | MP0003635_abnormal_synaptic_transmissio | 3.69029918 |
5 | MP0002822_catalepsy | 3.45798453 |
6 | MP0009046_muscle_twitch | 3.24952293 |
7 | MP0004270_analgesia | 3.20757958 |
8 | MP0009745_abnormal_behavioral_response | 3.14994744 |
9 | MP0001968_abnormal_touch/_nociception | 3.08209677 |
10 | MP0002064_seizures | 3.06770617 |
11 | MP0002063_abnormal_learning/memory/cond | 2.90976679 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.86538622 |
13 | MP0006082_CNS_inflammation | 2.80676960 |
14 | MP0008260_abnormal_autophagy | 2.65561647 |
15 | MP0002877_abnormal_melanocyte_morpholog | 2.65493444 |
16 | MP0002734_abnormal_mechanical_nocicepti | 2.57618125 |
17 | MP0002736_abnormal_nociception_after | 2.57246747 |
18 | MP0005423_abnormal_somatic_nervous | 2.55179724 |
19 | MP0002572_abnormal_emotion/affect_behav | 2.49970789 |
20 | MP0002272_abnormal_nervous_system | 2.38833972 |
21 | MP0003806_abnormal_nucleotide_metabolis | 2.35765770 |
22 | MP0005451_abnormal_body_composition | 2.34504916 |
23 | MP0002735_abnormal_chemical_nociception | 2.33374389 |
24 | MP0001501_abnormal_sleep_pattern | 2.28278317 |
25 | MP0000343_altered_response_to | 2.10200652 |
26 | MP0001486_abnormal_startle_reflex | 2.05906442 |
27 | MP0000015_abnormal_ear_pigmentation | 2.02559013 |
28 | MP0002909_abnormal_adrenal_gland | 2.00316957 |
29 | MP0001970_abnormal_pain_threshold | 1.99524661 |
30 | MP0009780_abnormal_chondrocyte_physiolo | 1.98673144 |
31 | MP0001440_abnormal_grooming_behavior | 1.98615317 |
32 | MP0002733_abnormal_thermal_nociception | 1.95996793 |
33 | MP0002067_abnormal_sensory_capabilities | 1.93010252 |
34 | MP0005257_abnormal_intraocular_pressure | 1.90403613 |
35 | MP0003300_gastrointestinal_ulcer | 1.90260124 |
36 | MP0005551_abnormal_eye_electrophysiolog | 1.88143000 |
37 | MP0002139_abnormal_hepatobiliary_system | 1.86169992 |
38 | MP0004858_abnormal_nervous_system | 1.85602261 |
39 | MP0008569_lethality_at_weaning | 1.84607329 |
40 | MP0010386_abnormal_urinary_bladder | 1.84286632 |
41 | MP0010352_gastrointestinal_tract_polyps | 1.82617303 |
42 | MP0003879_abnormal_hair_cell | 1.82426498 |
43 | MP0003329_amyloid_beta_deposits | 1.76242496 |
44 | MP0003183_abnormal_peptide_metabolism | 1.68407944 |
45 | MP0002148_abnormal_hypersensitivity_rea | 1.66138950 |
46 | MP0004924_abnormal_behavior | 1.61742087 |
47 | MP0005386_behavior/neurological_phenoty | 1.61742087 |
48 | MP0001984_abnormal_olfaction | 1.60679842 |
49 | MP0005646_abnormal_pituitary_gland | 1.56683411 |
50 | MP0004811_abnormal_neuron_physiology | 1.55156906 |
51 | MP0006054_spinal_hemorrhage | 1.49683123 |
52 | MP0002419_abnormal_innate_immunity | 1.45807693 |
53 | MP0004043_abnormal_pH_regulation | 1.45474063 |
54 | MP0003436_decreased_susceptibility_to | 1.44355052 |
55 | MP0003633_abnormal_nervous_system | 1.44085830 |
56 | MP0001502_abnormal_circadian_rhythm | 1.43268409 |
57 | MP0003724_increased_susceptibility_to | 1.42168392 |
58 | MP0002090_abnormal_vision | 1.41804459 |
59 | MP0002557_abnormal_social/conspecific_i | 1.41559444 |
60 | MP0002184_abnormal_innervation | 1.40981197 |
61 | MP0006276_abnormal_autonomic_nervous | 1.35976859 |
62 | MP0002998_abnormal_bone_remodeling | 1.34765821 |
63 | MP0005464_abnormal_platelet_physiology | 1.34149862 |
64 | MP0004885_abnormal_endolymph | 1.33290660 |
65 | MP0009785_altered_susceptibility_to | 1.31906669 |
66 | MP0003656_abnormal_erythrocyte_physiolo | 1.31114820 |
67 | MP0005165_increased_susceptibility_to | 1.27499918 |
68 | MP0003453_abnormal_keratinocyte_physiol | 1.26763108 |
69 | MP0000751_myopathy | 1.26255143 |
70 | MP0004147_increased_porphyrin_level | 1.26092520 |
71 | MP0002229_neurodegeneration | 1.24170193 |
72 | MP0002066_abnormal_motor_capabilities/c | 1.23449131 |
73 | MP0003172_abnormal_lysosome_physiology | 1.22953253 |
74 | MP0002882_abnormal_neuron_morphology | 1.21490509 |
75 | MP0003448_altered_tumor_morphology | 1.20019206 |
76 | MP0003950_abnormal_plasma_membrane | 1.18792201 |
77 | MP0000371_diluted_coat_color | 1.18685918 |
78 | MP0005645_abnormal_hypothalamus_physiol | 1.17541848 |
79 | MP0000604_amyloidosis | 1.17481476 |
80 | MP0001853_heart_inflammation | 1.17186113 |
81 | MP0008004_abnormal_stomach_pH | 1.15447000 |
82 | MP0003075_altered_response_to | 1.14667534 |
83 | MP0005174_abnormal_tail_pigmentation | 1.12755818 |
84 | MP0002837_dystrophic_cardiac_calcinosis | 1.11843296 |
85 | MP0000013_abnormal_adipose_tissue | 1.11793480 |
86 | MP0004142_abnormal_muscle_tone | 1.11716651 |
87 | MP0003787_abnormal_imprinting | 1.11413427 |
88 | MP0005409_darkened_coat_color | 1.10698428 |
89 | MP0000955_abnormal_spinal_cord | 1.10396057 |
90 | MP0004510_myositis | 1.10091518 |
91 | MP0003091_abnormal_cell_migration | 1.09889865 |
92 | MP0002876_abnormal_thyroid_physiology | 1.07693099 |
93 | MP0005167_abnormal_blood-brain_barrier | 1.07416782 |
94 | MP0003631_nervous_system_phenotype | 1.06302956 |
95 | MP0000569_abnormal_digit_pigmentation | 1.04053911 |
96 | MP0008872_abnormal_physiological_respon | 1.03652774 |
97 | MP0005058_abnormal_lysosome_morphology | 1.01489201 |
98 | MP0004947_skin_inflammation | 1.00615211 |
99 | MP0002638_abnormal_pupillary_reflex | 0.99427896 |
100 | MP0001533_abnormal_skeleton_physiology | 0.98917303 |
101 | MP0000778_abnormal_nervous_system | 0.98188161 |
102 | MP0003566_abnormal_cell_adhesion | 0.97372519 |
103 | MP0003632_abnormal_nervous_system | 0.96568571 |
104 | MP0005535_abnormal_body_temperature | 0.96521712 |
105 | MP0001664_abnormal_digestion | 0.96482560 |
106 | MP0003690_abnormal_glial_cell | 0.95981680 |
107 | MP0004019_abnormal_vitamin_homeostasis | 0.95959234 |
108 | MP0008961_abnormal_basal_metabolism | 0.95519069 |
109 | MP0001905_abnormal_dopamine_level | 0.95296735 |
110 | MP0009764_decreased_sensitivity_to | 0.94013553 |
111 | MP0005365_abnormal_bile_salt | 0.93719229 |
112 | MP0000358_abnormal_cell_content/ | 0.93566105 |
113 | MP0000858_altered_metastatic_potential | 0.92728334 |
114 | MP0005408_hypopigmentation | 0.92318176 |
115 | MP0001529_abnormal_vocalization | 0.90708018 |
116 | MP0003195_calcinosis | 0.90517001 |
117 | MP0008874_decreased_physiological_sensi | 0.89935706 |
118 | MP0003122_maternal_imprinting | 0.89211964 |
119 | MP0001765_abnormal_ion_homeostasis | 0.89121970 |
120 | MP0005253_abnormal_eye_physiology | 0.88999421 |
121 | MP0003634_abnormal_glial_cell | 0.88828194 |
122 | MP0001845_abnormal_inflammatory_respons | 0.88715928 |
123 | MP0004484_altered_response_of | 0.85206620 |
124 | MP0010678_abnormal_skin_adnexa | 0.84567319 |
125 | MP0003646_muscle_fatigue | 0.84012307 |
126 | MP0004215_abnormal_myocardial_fiber | 0.83297090 |
127 | MP0006072_abnormal_retinal_apoptosis | 0.82931864 |
128 | MP0002069_abnormal_eating/drinking_beha | 0.82361031 |
129 | MP0010155_abnormal_intestine_physiology | 0.81779025 |
130 | MP0005164_abnormal_response_to | 0.79310205 |
131 | MP0002332_abnormal_exercise_endurance | 0.78109606 |
132 | MP0004036_abnormal_muscle_relaxation | 0.78090106 |
133 | MP0001188_hyperpigmentation | 0.77404749 |
134 | MP0004130_abnormal_muscle_cell | 0.76657211 |
135 | MP0005000_abnormal_immune_tolerance | 0.76549042 |
136 | MP0005310_abnormal_salivary_gland | 0.74996129 |
137 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74352542 |
138 | MP0008469_abnormal_protein_level | 0.74059522 |
139 | MP0004085_abnormal_heartbeat | 0.74028554 |
140 | MP0004742_abnormal_vestibular_system | 0.72460967 |
141 | MP0005166_decreased_susceptibility_to | 0.72328687 |
142 | MP0001177_atelectasis | 0.72217450 |
143 | MP0005025_abnormal_response_to | 0.71644242 |
144 | MP0003186_abnormal_redox_activity | 0.69965039 |
145 | MP0003303_peritoneal_inflammation | 0.69957166 |
146 | MP0003828_pulmonary_edema | 0.69836503 |
147 | MP0000647_abnormal_sebaceous_gland | 0.69736602 |
148 | MP0001963_abnormal_hearing_physiology | 0.69493684 |
149 | MP0003866_abnormal_defecation | 0.68791158 |
150 | MP0000372_irregular_coat_pigmentation | 0.68194598 |
151 | MP0010234_abnormal_vibrissa_follicle | 0.67758595 |
152 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67545732 |
153 | MP0001986_abnormal_taste_sensitivity | 0.66852160 |
154 | MP0006035_abnormal_mitochondrial_morpho | 0.66334784 |
155 | MP0002152_abnormal_brain_morphology | 0.64974108 |
156 | MP0003283_abnormal_digestive_organ | 0.64934448 |
157 | MP0001756_abnormal_urination | 0.64677323 |
158 | MP0002254_reproductive_system_inflammat | 0.64573715 |
159 | MP0002896_abnormal_bone_mineralization | 0.63955445 |
160 | MP0002452_abnormal_antigen_presenting | 0.63864730 |
161 | MP0004233_abnormal_muscle_weight | 0.63322574 |
162 | MP0000920_abnormal_myelination | 0.63001015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.62653932 |
2 | Myokymia (HP:0002411) | 5.55142446 |
3 | Vacuolated lymphocytes (HP:0001922) | 5.28000636 |
4 | Visual hallucinations (HP:0002367) | 4.88799419 |
5 | Focal seizures (HP:0007359) | 4.83113483 |
6 | Epileptic encephalopathy (HP:0200134) | 4.66099713 |
7 | Loss of speech (HP:0002371) | 4.62543156 |
8 | Atonic seizures (HP:0010819) | 4.62077143 |
9 | Febrile seizures (HP:0002373) | 4.52744181 |
10 | Absence seizures (HP:0002121) | 4.18460396 |
11 | Dysostosis multiplex (HP:0000943) | 3.84587146 |
12 | Disinhibition (HP:0000734) | 3.84232010 |
13 | Progressive cerebellar ataxia (HP:0002073) | 3.77506488 |
14 | Generalized tonic-clonic seizures (HP:0002069) | 3.75804975 |
15 | Apathy (HP:0000741) | 3.73501013 |
16 | Dialeptic seizures (HP:0011146) | 3.72260337 |
17 | Diminished motivation (HP:0000745) | 3.67543181 |
18 | Supranuclear gaze palsy (HP:0000605) | 3.52721091 |
19 | Abnormality of macrophages (HP:0004311) | 3.48903793 |
20 | Abnormal eating behavior (HP:0100738) | 3.40968841 |
21 | Tetraparesis (HP:0002273) | 3.38642376 |
22 | Action tremor (HP:0002345) | 3.30977184 |
23 | Congenital stationary night blindness (HP:0007642) | 3.22583626 |
24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.19985551 |
25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.19985551 |
26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.19985551 |
27 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.14785840 |
28 | Mucopolysacchariduria (HP:0008155) | 3.14785840 |
29 | Axonal loss (HP:0003447) | 3.11479906 |
30 | Ankle clonus (HP:0011448) | 3.08088422 |
31 | Upper motor neuron abnormality (HP:0002127) | 3.06768323 |
32 | Pheochromocytoma (HP:0002666) | 3.05366123 |
33 | Depression (HP:0000716) | 3.00707566 |
34 | Central scotoma (HP:0000603) | 2.99472145 |
35 | Truncal ataxia (HP:0002078) | 2.97251339 |
36 | Dysdiadochokinesis (HP:0002075) | 2.97192068 |
37 | Mutism (HP:0002300) | 2.90655414 |
38 | Postural instability (HP:0002172) | 2.85643579 |
39 | Polyphagia (HP:0002591) | 2.82473471 |
40 | Gaze-evoked nystagmus (HP:0000640) | 2.81652301 |
41 | Anxiety (HP:0000739) | 2.74503594 |
42 | Abnormality of binocular vision (HP:0011514) | 2.72775895 |
43 | Diplopia (HP:0000651) | 2.72775895 |
44 | Neuroendocrine neoplasm (HP:0100634) | 2.68474397 |
45 | Dysmetric saccades (HP:0000641) | 2.66373149 |
46 | Agnosia (HP:0010524) | 2.66244906 |
47 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.63997119 |
48 | Broad-based gait (HP:0002136) | 2.63541294 |
49 | Nuclear cataract (HP:0100018) | 2.63407070 |
50 | Myocardial infarction (HP:0001658) | 2.63075447 |
51 | Poor eye contact (HP:0000817) | 2.60034603 |
52 | Hyperventilation (HP:0002883) | 2.59575436 |
53 | Ventricular fibrillation (HP:0001663) | 2.56603915 |
54 | Impaired social interactions (HP:0000735) | 2.52831422 |
55 | Abnormal social behavior (HP:0012433) | 2.52831422 |
56 | Increased cerebral lipofuscin (HP:0011813) | 2.51615852 |
57 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.49129677 |
58 | Dysmetria (HP:0001310) | 2.47197623 |
59 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.45763989 |
60 | Progressive inability to walk (HP:0002505) | 2.43545704 |
61 | Progressive neurologic deterioration (HP:0002344) | 2.43427041 |
62 | Abnormality of macular pigmentation (HP:0008002) | 2.42129372 |
63 | Dementia (HP:0000726) | 2.38742760 |
64 | Eczematoid dermatitis (HP:0000976) | 2.37641238 |
65 | Hemiplegia (HP:0002301) | 2.37468936 |
66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.34719622 |
67 | Spastic tetraparesis (HP:0001285) | 2.34419345 |
68 | Metabolic alkalosis (HP:0200114) | 2.33036399 |
69 | Bradykinesia (HP:0002067) | 2.32924854 |
70 | Papilledema (HP:0001085) | 2.31657448 |
71 | Hand muscle atrophy (HP:0009130) | 2.31370604 |
72 | Resting tremor (HP:0002322) | 2.29554198 |
73 | Failure to thrive in infancy (HP:0001531) | 2.29336766 |
74 | Metaphyseal irregularity (HP:0003025) | 2.27065412 |
75 | Inappropriate behavior (HP:0000719) | 2.26913055 |
76 | Scanning speech (HP:0002168) | 2.24861540 |
77 | Hypokinesia (HP:0002375) | 2.23042995 |
78 | Recurrent abscess formation (HP:0002722) | 2.22907611 |
79 | Urinary urgency (HP:0000012) | 2.21157037 |
80 | Abnormal neuron morphology (HP:0012757) | 2.19869521 |
81 | Abnormality of the motor neurons (HP:0002450) | 2.19869521 |
82 | Increased circulating renin level (HP:0000848) | 2.18003674 |
83 | Tetraplegia (HP:0002445) | 2.14977449 |
84 | Neuronal loss in central nervous system (HP:0002529) | 2.14751417 |
85 | Genetic anticipation (HP:0003743) | 2.12820941 |
86 | Amblyopia (HP:0000646) | 2.12309366 |
87 | Recurrent bacterial skin infections (HP:0005406) | 2.11995579 |
88 | Personality changes (HP:0000751) | 2.11604590 |
89 | Distal upper limb amyotrophy (HP:0007149) | 2.11333240 |
90 | Upper limb amyotrophy (HP:0009129) | 2.11333240 |
91 | Increased CSF protein (HP:0002922) | 2.10762338 |
92 | Systemic lupus erythematosus (HP:0002725) | 2.09332685 |
93 | Amyotrophic lateral sclerosis (HP:0007354) | 2.09041453 |
94 | Delusions (HP:0000746) | 2.07776912 |
95 | Prolonged neonatal jaundice (HP:0006579) | 2.06926758 |
96 | Impaired smooth pursuit (HP:0007772) | 2.05646610 |
97 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05164521 |
98 | Prolonged QT interval (HP:0001657) | 2.04663082 |
99 | J-shaped sella turcica (HP:0002680) | 2.03743911 |
100 | Vertebral compression fractures (HP:0002953) | 2.01727177 |
101 | Abnormal EKG (HP:0003115) | 2.01422611 |
102 | Torticollis (HP:0000473) | 1.99437479 |
103 | Fetal akinesia sequence (HP:0001989) | 1.98931283 |
104 | Psychosis (HP:0000709) | 1.98871761 |
105 | Abnormality of the periventricular white matter (HP:0002518) | 1.98632201 |
106 | Upper limb muscle weakness (HP:0003484) | 1.98562379 |
107 | Epileptiform EEG discharges (HP:0011182) | 1.98495435 |
108 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.98467045 |
109 | Status epilepticus (HP:0002133) | 1.98064931 |
110 | Scotoma (HP:0000575) | 1.97977713 |
111 | Stereotypic behavior (HP:0000733) | 1.97255374 |
112 | Hypercortisolism (HP:0001578) | 1.97191924 |
113 | Hypoventilation (HP:0002791) | 1.97084011 |
114 | Syncope (HP:0001279) | 1.96726429 |
115 | Cardiomegaly (HP:0001640) | 1.95909203 |
116 | Agitation (HP:0000713) | 1.93985346 |
117 | Hepatosplenomegaly (HP:0001433) | 1.93427483 |
118 | Urinary incontinence (HP:0000020) | 1.90232840 |
119 | Retinal atrophy (HP:0001105) | 1.89512204 |
120 | Hemiparesis (HP:0001269) | 1.89417541 |
121 | Hyperactive renin-angiotensin system (HP:0000841) | 1.89074601 |
122 | Inability to walk (HP:0002540) | 1.89070832 |
123 | Intention tremor (HP:0002080) | 1.88882263 |
124 | Neurofibrillary tangles (HP:0002185) | 1.88812107 |
125 | Bone pain (HP:0002653) | 1.88727322 |
126 | EEG with generalized epileptiform discharges (HP:0011198) | 1.88515662 |
127 | Rigidity (HP:0002063) | 1.86589617 |
128 | Abnormality of saccadic eye movements (HP:0000570) | 1.86405462 |
129 | Sensorimotor neuropathy (HP:0007141) | 1.86200802 |
130 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.85866693 |
131 | Spastic gait (HP:0002064) | 1.85839342 |
132 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.85339697 |
133 | Gait imbalance (HP:0002141) | 1.84720723 |
134 | Malnutrition (HP:0004395) | 1.84577643 |
135 | Akinesia (HP:0002304) | 1.84251154 |
136 | Adrenal overactivity (HP:0002717) | 1.84065185 |
137 | Drooling (HP:0002307) | 1.83809002 |
138 | Excessive salivation (HP:0003781) | 1.83809002 |
139 | Lower limb muscle weakness (HP:0007340) | 1.83697364 |
140 | Abnormality of renin-angiotensin system (HP:0000847) | 1.83573501 |
141 | Oligomenorrhea (HP:0000876) | 1.83393783 |
142 | Interstitial pulmonary disease (HP:0006530) | 1.83297469 |
143 | Ocular albinism (HP:0001107) | 1.82760958 |
144 | Abnormality of the lower motor neuron (HP:0002366) | 1.82591336 |
145 | Tongue fasciculations (HP:0001308) | 1.82491644 |
146 | Decreased circulating renin level (HP:0003351) | 1.82490836 |
147 | Rapidly progressive (HP:0003678) | 1.81512628 |
148 | Focal dystonia (HP:0004373) | 1.81172234 |
149 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.81062902 |
150 | Termporal pattern (HP:0011008) | 1.80730601 |
151 | Insidious onset (HP:0003587) | 1.80730601 |
152 | Spinal canal stenosis (HP:0003416) | 1.80435744 |
153 | Hydroxyprolinuria (HP:0003080) | 1.80048648 |
154 | Abnormality of proline metabolism (HP:0010907) | 1.80048648 |
155 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.79678110 |
156 | Peripheral hypomyelination (HP:0007182) | 1.79212010 |
157 | Amyloidosis (HP:0011034) | 1.79147778 |
158 | Generalized myoclonic seizures (HP:0002123) | 1.78934410 |
159 | Papillary thyroid carcinoma (HP:0002895) | 1.77780268 |
160 | Bundle branch block (HP:0011710) | 1.76644358 |
161 | Global brain atrophy (HP:0002283) | 1.76567308 |
162 | Symptomatic seizures (HP:0011145) | 1.76516057 |
163 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76236619 |
164 | Cerebral inclusion bodies (HP:0100314) | 1.73109410 |
165 | Postural tremor (HP:0002174) | 1.72681847 |
166 | Cholecystitis (HP:0001082) | 1.72378684 |
167 | Abnormal gallbladder physiology (HP:0012438) | 1.72378684 |
168 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71397640 |
169 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71397640 |
170 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71397640 |
171 | Cortical dysplasia (HP:0002539) | 1.70214801 |
172 | Pathologic fracture (HP:0002756) | 1.70133477 |
173 | Multiple enchondromatosis (HP:0005701) | 1.68250262 |
174 | Peripheral demyelination (HP:0011096) | 1.67183955 |
175 | Protuberant abdomen (HP:0001538) | 1.65844923 |
176 | Iris hypopigmentation (HP:0007730) | 1.64471721 |
177 | Steatorrhea (HP:0002570) | 1.64425883 |
178 | Horizontal nystagmus (HP:0000666) | 1.63997684 |
179 | Cerebral hemorrhage (HP:0001342) | 1.63593642 |
180 | Hematochezia (HP:0002573) | 1.63341585 |
181 | Abnormality of the costochondral junction (HP:0000919) | 1.61461314 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.84164535 |
2 | ACVR1B | 3.53122805 |
3 | MAP3K9 | 3.45633297 |
4 | IRAK3 | 3.42575192 |
5 | MAP3K12 | 3.04311495 |
6 | EPHA4 | 2.83556465 |
7 | MAP3K4 | 2.79033207 |
8 | MINK1 | 2.58578305 |
9 | MAP2K7 | 2.54844200 |
10 | DAPK2 | 2.33089196 |
11 | CASK | 2.30365686 |
12 | PBK | 2.29053054 |
13 | KSR2 | 2.25805982 |
14 | MARK1 | 2.18842337 |
15 | TESK1 | 2.14769221 |
16 | RIPK4 | 2.08599372 |
17 | PAK6 | 2.05370299 |
18 | CAMKK1 | 2.03367326 |
19 | LIMK1 | 1.96648414 |
20 | LATS2 | 1.88811007 |
21 | PAK4 | 1.85508278 |
22 | TRIM28 | 1.83544410 |
23 | MAP2K4 | 1.82180254 |
24 | ARAF | 1.75070891 |
25 | NTRK1 | 1.72030578 |
26 | LMTK2 | 1.69312522 |
27 | CAMKK2 | 1.66188426 |
28 | MAP3K14 | 1.64461925 |
29 | PRPF4B | 1.64107079 |
30 | NTRK2 | 1.61975192 |
31 | MAP3K3 | 1.59084891 |
32 | FGR | 1.56443114 |
33 | ERBB4 | 1.55165683 |
34 | DAPK1 | 1.53973359 |
35 | MAP3K2 | 1.48641369 |
36 | MAP3K13 | 1.42387806 |
37 | STK38 | 1.41494110 |
38 | GRK5 | 1.41023640 |
39 | PLK2 | 1.39548664 |
40 | MATK | 1.39482769 |
41 | CDK5 | 1.37812219 |
42 | ABL2 | 1.36514653 |
43 | BCR | 1.29787601 |
44 | CDK19 | 1.24981863 |
45 | OXSR1 | 1.24783295 |
46 | SGK223 | 1.24254983 |
47 | SGK494 | 1.24254983 |
48 | FES | 1.24031510 |
49 | PRKD3 | 1.23442075 |
50 | YES1 | 1.22870125 |
51 | CSNK1G2 | 1.17699588 |
52 | EIF2AK3 | 1.16729514 |
53 | MST4 | 1.16709337 |
54 | ERBB3 | 1.15479281 |
55 | PHKG2 | 1.14998088 |
56 | PHKG1 | 1.14998088 |
57 | MST1R | 1.13778282 |
58 | SGK2 | 1.12846162 |
59 | TAOK2 | 1.11874176 |
60 | KSR1 | 1.10082839 |
61 | MAP3K5 | 1.08106309 |
62 | SGK3 | 1.05835263 |
63 | NEK1 | 1.04067989 |
64 | EPHA2 | 1.03002829 |
65 | NEK6 | 1.02609973 |
66 | PINK1 | 1.01570618 |
67 | PRKCH | 1.01244331 |
68 | PRKCG | 1.01212673 |
69 | TBK1 | 0.95625664 |
70 | TAOK1 | 0.95477286 |
71 | TSSK6 | 0.93910902 |
72 | NME2 | 0.93482862 |
73 | SIK2 | 0.92176876 |
74 | MOS | 0.91689472 |
75 | DDR2 | 0.90580572 |
76 | EIF2AK1 | 0.90549952 |
77 | AKT3 | 0.90175027 |
78 | MAP3K1 | 0.89751068 |
79 | RIPK1 | 0.88743384 |
80 | TYK2 | 0.87754664 |
81 | TNK2 | 0.87746337 |
82 | CAMK2A | 0.87230881 |
83 | CSNK1G3 | 0.86711882 |
84 | EPHB1 | 0.85941261 |
85 | RET | 0.85335937 |
86 | PIM2 | 0.80975473 |
87 | PAK3 | 0.80094816 |
88 | SCYL2 | 0.73517763 |
89 | CAMK1 | 0.71746572 |
90 | PDK1 | 0.70372922 |
91 | SIK3 | 0.70035265 |
92 | IRAK2 | 0.68967192 |
93 | PDPK1 | 0.68917874 |
94 | TGFBR2 | 0.68867493 |
95 | PRKCE | 0.68734184 |
96 | MYLK | 0.68535229 |
97 | CSNK1A1L | 0.68406751 |
98 | MAPK13 | 0.67937987 |
99 | FER | 0.67563902 |
100 | SGK1 | 0.67008470 |
101 | CDK18 | 0.66462666 |
102 | WNK3 | 0.66271038 |
103 | STK11 | 0.65813153 |
104 | PDGFRA | 0.64663424 |
105 | ALK | 0.64341122 |
106 | WNK1 | 0.64268838 |
107 | WNK4 | 0.64017264 |
108 | MAP2K1 | 0.63405920 |
109 | BMPR2 | 0.63341387 |
110 | ROCK2 | 0.62639574 |
111 | CDK15 | 0.62464529 |
112 | CDK14 | 0.61900127 |
113 | CAMK2D | 0.61253621 |
114 | CDK6 | 0.60405100 |
115 | RAF1 | 0.59142634 |
116 | NME1 | 0.58962225 |
117 | PTK2 | 0.58390703 |
118 | UHMK1 | 0.57845945 |
119 | GRK7 | 0.57645473 |
120 | PDK2 | 0.56462575 |
121 | CAMK2B | 0.56230563 |
122 | MAP3K11 | 0.53639333 |
123 | TNIK | 0.53037413 |
124 | FYN | 0.52256689 |
125 | RPS6KA2 | 0.52219281 |
126 | PTK2B | 0.51094366 |
127 | CDK11A | 0.50150192 |
128 | CDC42BPA | 0.48496888 |
129 | DAPK3 | 0.48398506 |
130 | FRK | 0.47712562 |
131 | CAMK2G | 0.47407739 |
132 | EGFR | 0.46642846 |
133 | PDK3 | 0.46205616 |
134 | PDK4 | 0.46205616 |
135 | ZAP70 | 0.45716769 |
136 | BRAF | 0.43325821 |
137 | PRKCZ | 0.42901511 |
138 | CSNK1G1 | 0.41432666 |
139 | RPS6KA3 | 0.41256212 |
140 | MAP3K7 | 0.39969884 |
141 | ADRBK1 | 0.38753088 |
142 | JAK1 | 0.38487179 |
143 | PRKG2 | 0.36861326 |
144 | CSK | 0.36670011 |
145 | JAK2 | 0.36655529 |
146 | TESK2 | 0.36113838 |
147 | CCNB1 | 0.34660572 |
148 | DYRK1A | 0.34371962 |
149 | MAPK12 | 0.34121780 |
150 | PRKCA | 0.33735004 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.74564599 |
2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.53647975 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.11322344 |
4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.09289639 |
5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.54771534 |
6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53399912 |
7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.47519552 |
8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.42383596 |
9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.33970306 |
10 | Morphine addiction_Homo sapiens_hsa05032 | 2.28004311 |
11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23459899 |
12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.20803742 |
13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.93698010 |
14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.93456688 |
15 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.88268765 |
16 | Salivary secretion_Homo sapiens_hsa04970 | 1.87528160 |
17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85999657 |
18 | Phototransduction_Homo sapiens_hsa04744 | 1.79892408 |
19 | Insulin secretion_Homo sapiens_hsa04911 | 1.79890136 |
20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.77517935 |
21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.74918897 |
22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.74238319 |
23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.69958288 |
24 | Legionellosis_Homo sapiens_hsa05134 | 1.64588154 |
25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.61880021 |
26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.58007683 |
27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.57543223 |
28 | Renin secretion_Homo sapiens_hsa04924 | 1.56901843 |
29 | Taste transduction_Homo sapiens_hsa04742 | 1.53271729 |
30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48985559 |
31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.45105555 |
32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41922663 |
33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39803048 |
34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39368967 |
35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36822200 |
36 | Shigellosis_Homo sapiens_hsa05131 | 1.35815354 |
37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34476539 |
38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.33955488 |
39 | Long-term depression_Homo sapiens_hsa04730 | 1.28444483 |
40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27337366 |
41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.26667993 |
42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.25636652 |
43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.23304494 |
44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22600095 |
45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22043382 |
46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19167528 |
47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15093666 |
48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13316615 |
49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13112131 |
50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12876386 |
51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11113087 |
52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08705947 |
53 | Pertussis_Homo sapiens_hsa05133 | 1.07053996 |
54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04485941 |
55 | Gap junction_Homo sapiens_hsa04540 | 1.01493465 |
56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01130275 |
57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99429359 |
58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.98181603 |
59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95449972 |
60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94808023 |
61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93301529 |
62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.92724593 |
63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.92514571 |
64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88026144 |
65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86359684 |
66 | Mineral absorption_Homo sapiens_hsa04978 | 0.86089384 |
67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85156852 |
68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83103751 |
69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80051392 |
70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79482412 |
71 | Glioma_Homo sapiens_hsa05214 | 0.78190583 |
72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78140216 |
73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.77794344 |
74 | Lysosome_Homo sapiens_hsa04142 | 0.76100165 |
75 | Phagosome_Homo sapiens_hsa04145 | 0.75897975 |
76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75297695 |
77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74267549 |
78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71046891 |
79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69540850 |
80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68171351 |
81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67137303 |
82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66673143 |
83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65817960 |
84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62342594 |
85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62091748 |
86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62027241 |
87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61136935 |
88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60150336 |
89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59869097 |
90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59494870 |
91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59055829 |
92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57998017 |
93 | Endocytosis_Homo sapiens_hsa04144 | 0.57910183 |
94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56954845 |
95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55499472 |
96 | Bladder cancer_Homo sapiens_hsa05219 | 0.55014193 |
97 | Bile secretion_Homo sapiens_hsa04976 | 0.54346850 |
98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54041437 |
99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54004874 |
100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53607089 |
101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53096071 |
102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51155631 |
103 | Salmonella infection_Homo sapiens_hsa05132 | 0.50916403 |
104 | Tuberculosis_Homo sapiens_hsa05152 | 0.50435063 |
105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50394232 |
106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49231065 |
107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48969463 |
108 | Melanogenesis_Homo sapiens_hsa04916 | 0.48649541 |
109 | Hepatitis C_Homo sapiens_hsa05160 | 0.48274298 |
110 | Axon guidance_Homo sapiens_hsa04360 | 0.48028168 |
111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47628068 |
112 | Amoebiasis_Homo sapiens_hsa05146 | 0.47420152 |
113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46317381 |
114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43725505 |
115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43720677 |
116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43403584 |
117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43186383 |
118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43031908 |
119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42327962 |
120 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39384667 |
121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39088761 |
122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39030066 |
123 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.38387437 |
124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38230662 |
125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38090018 |
126 | Apoptosis_Homo sapiens_hsa04210 | 0.37448890 |
127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37352015 |
128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36417187 |
129 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.36384983 |
130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36331189 |
131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36286790 |
132 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35649420 |
133 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35414826 |
134 | Influenza A_Homo sapiens_hsa05164 | 0.35324545 |
135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34502868 |
136 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.34450956 |
137 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34413608 |
138 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33574465 |
139 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32109624 |
140 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31071054 |
141 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30351560 |
142 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30335816 |
143 | Protein export_Homo sapiens_hsa03060 | 0.29877037 |
144 | Prion diseases_Homo sapiens_hsa05020 | 0.29797802 |
145 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29150987 |
146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29004362 |
147 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28095452 |
148 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.27250163 |
149 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25424965 |
150 | Hepatitis B_Homo sapiens_hsa05161 | 0.23590398 |